Pain Market Research Reports & Industry Analysis
In considering the IASP definition, it is important to note that not all potentially tissue-damaging stimuli result in pain. Nociception is the activation of the primary afferent nerves with peripheral terminals that respond differently to noxious stimuli. Nociceptors function primarily to sense and transmit pain signals. Nociception may or may not be perceived as pain, depending on a complex interaction within the nociceptive pathways. If nociceptive stimuli are blocked, pain is not perceived. Finally, it is important to distinguish pain, or nociception, from suffering. Suffering is the state of severe distress associated with events that threaten the intactness of the person. Suffering is an emotion. Pain and suffering are not the same phenomenon.
The person who complained of pain in the heart because of the death of a loved one is suffering rather than experiencing pain as it is defined by the IASP. It is clear that three conditions could exist: 1) suffering occurs in the presence of pain,2) suffering occurs when pain is not present, and 3) pain occurs when suffering is not present. For example, the woman awaiting breast biopsy may suffer because of anticipated loss of her breast. After the biopsy, she may have pain without suffering if the biopsy is negative or pain with suffering if the biopsy is positive for malignancy. Interventions aimed at relieving pain and suffering may have some commonalities, but clearly some interventions for suffering will be inadequate for pain just as some interventions for pain are inadequate for suffering.
Pain Industry Research & Market Reports
-
Pain Management Devices Market, By Product Type (Electrical Stimulators (TENS, Others), Radiofrequency Ablation, Analgesic Pumps(Intrathecal, External), Neurostimulation Devices (Spinal Cord Stimulation, Sacral Stimulation, Deep Brain Stimulation)), and B
... Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Pain Management Devices are used long-term treatment of pain especially for chronic conditions such as cancer and arthritis. Electrical currents, ... Read More
-
Europe Cryochambers Market, By Product Type (Individual Units/Cryopods (Devices, Services), Cryochambers/Multiple person chambers (Devices, Services)), By Application (Dermatology & Beauty Applications, Sports Medicine & Pain Management, Others), By End U
... Cryotherapy Centers, Sports Clubs and Athletes Clubs, Others), and By Countries (Germany, Italy, France, U.K., Spain, Poland, Belgium, Netherlands, Czech Republic, Rest of Europe) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Cryotherapy, ... Read More
-
Fibromyalgia Treatment Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022 - 2028
... of fibromyalgia is unknown, however, it can be caused due to various factors, including genetics cause, physical or emotional trauma or due to infections. The symptoms related to fibromyalgia includes widespread pain, severe fatigue, sleep ... Read More
-
U.S. 503B Compounding Pharmacies Market, by Molecule (Acetaminophen, Phenylephrine, Midazolam, Esmolol, Vancomycin, Epinephrine, Adenocaine, Fentanyl/Bupivacaine, Morphine, Amiodarone, Heparin, Ketamine, Dextrose, Hydromorphone, Bupivacaine, Lidocaine, BK
... Ketorolac, and Ketamine), and Other Molecules), and by Packaging (Vials, Prefilled Syringes, Ampoules, Syringes, and Others) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 In the U.S. 503B compounding pharmacies market, conventional compounding ... Read More
-
Cryotherapy Market, by Product Type (Cryosurgery Devices (Cryo Probes and Cryoablation Devices), Localized Cryotherapy Devices, and Cryochambers & Cryosaunas), by Application (Cancer, Cardiovascular Diseases, Dermatologic Disorders, Pain Management, and O
... Specialty Clinics, Cryotherapy Clinics, and Spas & Fitness Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Cryotherapy is ... Read More
-
Opioids Market By Product Type (Methadone, Codeine, Fentanyl, Oxycodone, Morphine, Hydrocodone, Others), By Application (Pain Management, Cough Treatment, Diarrhea Treatment): Global Opportunity Analysis and Industry Forecast, 2020-2030
... that relax muscles and alleviate pain and stress. Prescription opioids are primarily used to treat moderate to severe pain, while some opioids can be used to alleviate coughing and diarrhea. Hydrocodone, oxycodone, codeine, fentanyl, methadone, ... Read More
-
Morphine, Buprenorphine, and Other Drugs Market, by Drug (Morphine, Buprenorphine, Noscapine, Thebaine, and Etrophine), by Application (Pain Management, Opioid Addiction Treatment, and Others), by Route Of Administration (Injectable, Oral, and Transdermal
... Pharmacies, Retail Pharmacies, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Morphine, buprenorphine, and other similar drugs ... Read More
-
South Korea VR In Healthcare Market Forecast 2022-2028
... the market’s study is 2021, and the forecasted years are from 2022 to 2028. Some of the key factors influencing the country’s market growth include the increasing technological developments and innovations as well as the ... Read More
-
Global Neurology Patient Monitoring Market Size study, by Application (Trauma, CSF Management, Migraine, Stroke, Hydrocephalus, EEG, Others), and Regional Forecasts 2022-2028
... and is anticipated to grow with a healthy growth rate of more than 7.0 % over the forecast period 2022-2028. Neurology Patient Monitoring is basically providing an opportunity to treat and diagnose patients facing neurological ... Read More
-
Clinical Trials Market Size, Share & Trends Analysis Report By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design, By Indication (Pain Management, Oncology, CNS Condition, Diabetes, Obesity), By Region, And Segment Forecasts, 2022 - 2030
... by Grand View Research, Inc. An increase in the volume and complexity of clinical trials has been witnessed lately, which plays an important role in the R&D of new drugs and products. The market witnessed ... Read More
-
Pain Management Devices Market Size, Share & Trends Analysis Report By Product (RFA, Neurostimulation), By Application (Neuropathic Pain, Cancer), By Region (APAC, North America), And Segment Forecasts, 2022 - 2030
... new report by Grand View Research, Inc. Increasing prevalence of chronic pain and technological advancements are driving the market growth. The rising prevalence of chronic diseases, coupled with the increasing geriatric population, across the globe ... Read More
-
Global Non-opioid Pain Patches Market Size study, by Product Type (Lidocaine Patches, Diclofenac Patches, Methyl Salicylate Patches, Capsaicin Patches, Ketoprofen Patches, Others) by Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies) and Regional Forecasts 2022-2028
... Regional Forecasts 2022-2028 Global Non-opioid Pain Patches Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period ... Read More
-
Europe Pharmacogenomics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (PCR, Sequencing, Microarray, Gel Electrophoresis, Mass Spectrometry, and Others), Application (Drug Discovery, Oncology, Neurology and Psychiatry, Pain Management, Cardiovascular Diseases, and Others), and End User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others)
... Others), and End User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others) The Europe pharmacogenomics market is expected to reach US$ 3,874.31 million by 2028 from US$ 1,962.48 million in 2021. It is ... Read More
-
Global Pelvic Floor Diagnostics Market Size study, by Product (Urodynamics Systems, Uroflowmetry Devices, Anal Manometry Systems, Cystoscopes, Ultrasound Systems, Electromyography (EMG)) by end use industries (Hospitals, Diagnostic Imaging Centres, Specialty Clinics) and Regional Forecasts 2022-2028
... Global Pelvic Floor Diagnostics Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. Pelvic floor ... Read More
-
South and Central America Pharmacogenomics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (PCR, Sequencing, Microarray, Gel Electrophoresis, Mass Spectrometry, and Others), Application (Drug Discovery, Oncology, Neurology and Psychiatry, Pain Management, Cardiovascular Diseases, and Others), and End User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others)
... Cardiovascular Diseases, and Others), and End User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others) The South and Central America pharmacogenomics market is expected to reach US$ 591.35 million by 2028 from US$ ... Read More
-
Middle East and Africa Pharmacogenomics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (PCR, Sequencing, Microarray, Gel Electrophoresis, Mass Spectrometry, and Others), Application (Drug Discovery, Oncology, Neurology and Psychiatry, Pain Management, Cardiovascular Diseases, and Others), and End User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others)
... Cardiovascular Diseases, and Others), and End User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others) The Middle East and Africa pharmacogenomics market is expected to reach US$ 427.68 million by 2028 from US$ ... Read More
-
North America Pharmacogenomics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (PCR, Sequencing, Microarray, Gel Electrophoresis, Mass Spectrometry, and Others), Application (Drug Discovery, Oncology, Neurology and Psychiatry, Pain Management, Cardiovascular Diseases, and Others), and End User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others)
... and Others), and End User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others) The North America pharmacogenomics market is expected to reach US$ 6,534.83 million by 2028 from US$ 3,333.43 million in 2021. ... Read More
-
U.S. Ambulatory Surgery Centers Market Size, Share & Trends Analysis Report By Application (Orthopedics, Pain Management/Spinal Injections), And Segment Forecasts, 2022 - 2030
... centers market size is expected to reach USD 58.6 billion by 2030, expanding at a CAGR of 5.9%, according to a new report by Grand View Research, Inc. The cost-effectiveness of procedures performed at ASCs ... Read More
-
2022 Global Forecast for Veterinary Pain Management (2023-2028 Outlook)-High Tech & Emerging Markets Report
... The global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product ... Read More
-
Asia Pacific Pharmacogenomics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (PCR, Sequencing, Microarray, Gel Electrophoresis, Mass Spectrometry, and Others), Application (Drug Discovery, Oncology, Neurology and Psychiatry, Pain Management, Cardiovascular Diseases, and Others), and End User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others)
... and Others), and End User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others) The Asia Pacific pharmacogenomics market is expected to reach US$ 2,679.64 million by 2028 from US$ 1,148.36 million in 2021. ... Read More
-
Leading Intrathecal Pumps Country Markets Databank
... 2029. Asia-Pacific is expected to be the highest contributor to this market, with $59.2 Million in 2020, and is anticipated to reach $177.4 Million by 2029, registering a CAGR of 13.02%. Asia-Pacific and North America ... Read More
-
Insomnia Market By Therapy Type (Non pharmacological Therapy, Pharmacological Therapy): Global Opportunity Analysis and Industry Forecast, 2020-2030
... 6,315.9 million by 2030, registering a CAGR of 3.9% from 2021 to 2030. Insomnia is a sleep disorder wherein people find it difficult to sleep or remain asleep. The symptoms for insomnia include, low stamina, ... Read More
-
Leading Minor Cannabinoids Country Markets Databank
... 2029. Asia-Pacific is expected to be the highest contributor to this market, with $2,718.5 Million in 2020, and is anticipated to reach $5,888.3 Million by 2029, registering a CAGR of 9.01%. Asia-Pacific and North America ... Read More
-
Europe Minor Cannabinoids Market Databank
... Cannabigerol (CBG) segment is expected to be the highest contributor to this market, with $2,174.2 Million in 2020, and is anticipated to reach $4,198.5 Million by 2029, registering a CAGR of 7.64%. Cannabigerolic acid (CBGA) ... Read More
-
North America Intrathecal Pumps Market Databank
... from 2021 to 2029. Pain segment is expected to be the highest contributor to this market, with $137.6 Million in 2020, and is anticipated to reach $377.3 Million by 2029, registering a CAGR of 11.91%. Read More
Research Assistance
